Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Selling, general and administrative

Equity earnings (loss) in AmerisourceBergen

Impairment of goodwill

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

Walgreens

Duane Reade is a subsidiary of Walgreens Boots Alliance, is a chain of pharmacy and convenience stores, primarily located in New York City, known for its high volume small store layouts in densely populated Manhattan locations.

Duane Reade

Boots UK is a pharmacy chain in the United Kingdom, Ireland, Norway, Thailand and other territories. Boots became a subsidiary of the new company, Walgreens Boots Alliance, on 31 December 2014.

Boots UK

Alliance Healthcare was formerly Alliance UniChem, wholesales, distributes, and retails pharmaceutical, surgical, medical, and healthcare products throughout Europe. The company supplies more than 110,000 pharmacies, doctors, health centres and hospitals from over 288 distribution centres in 11 countries. The company is a wholly owned subsidiary of Walgreens Boots Alliance, which was formed by the merger of Walgreens with its former parent Alliance Boots in 2014. Alliance Boots had itself been formed in 2006 by the merger of Boots Group and Alliance UniChem on 31 July 2006. Alliance UniChem was rebranded Alliance Healthcare in 2009.

Alliance Healthcare

Walgreens Boots Alliance, Inc. engages in the provision of healthcare and retail pharmacy services. It operates through the following segments: United States Retail Pharmacy, International, and United States Healthcare. The US Retail Pharmacy segment includes the operation of retail drugstores, health and wellness services, specialty and home delivery pharmacy services, and equity method investment. The International segment offers pharmacy-led health and beauty retail businesses outside the US and the pharmaceutical wholesaling and distribution business in Germany. The US Healthcare segment delivers improved health outcomes and lower costs for payors and providers through owned and partnered assets. The company was founded by Charles R. Walgreen and John Boot in 1909 and is headquartered in Deerfield, IL.

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Earnings data Q1 2025

Walgreens reports Q1 earnings decline, eyes growth opportunities ahead

Walgreens faces challenges from COVID impacts and investments but is on track to achieve full-year guidance.
Strategic acquisitions and scaling U.S. Healthcare present opportunities for growth and profitability.
Despite first-half declines, the company anticipates improvements in margins and performance in the second half.
Efforts to optimize cash flow and investments position Walgreens for future growth and success.

Walgreens reports 4.5% sales growth in Q2 2023 earnings

Walgreens remains cautiously optimistic about managing potential changes in health plans and anticipates a strong second half of the year. The company is targeting debt reduction and small tuck-on acquisitions in healthcare as capital allocation priorities.

Walgreens (WBA) reports mixed Q3 performance, focuses on profitability

Walgreens (WBA) Q3 2023 earnings call highlights mixed performance with a focus on profitability enhancement.
Strategic partnerships, cost management programs, and capital allocation priorities support long-term value creation.
Challenges in margin pressures, script growth, and operational issues require immediate actions for profitability.
Opportunities lie in unlocking profitability, market developments, and demand for risk-based health care services.

Walgreens appoints new CEO to drive cost savings and script growth opportunities

Walgreens is strategically positioning itself for operational efficiency and cost savings in fiscal year 2024. The company's new CEO, Tim Wentworth, is expected to drive healthcare expertise and cost-effective outcomes. Despite challenges like lower contributions and segment declines, Walgreens is leveraging opportunities for script growth and financial improvement.

Walgreens Q1 Earnings: Navigating Challenges, Focused on Value Creation

Walgreens is navigating challenges in the pharmacy sector while focusing on strategic initiatives to drive value creation and sustainable growth. The company's emphasis on partnerships, cost-saving actions, and a shift towards value-based reimbursement models positions them for future success in the evolving healthcare landscape.

Walgreens reports solid Q2 results, focuses on growth strategies

Walgreens navigates retail challenges with strong operational performance. Focus on cost discipline, portfolio optimization, and cash flow improvement. Strategic decisions to drive growth and unlock value in healthcare areas.

Walgreens Q3 Earnings Miss Expectations Amid Challenges

Walgreens' Q3 2024 earnings call highlighted a challenging quarter with missed expectations, driven by pressures in the retail pharmacy sector and adverse market conditions. CEO Tim Wentworth emphasized ongoing strategic reviews and cost management initiatives as key to navigating these challenges. The company remains committed to transforming its business model to better serve customers and improve operational efficiency.

Walgreens (WBA) reports Q4 earnings, focuses on growth strategies

Walgreens (WBA) focused on financial stability, cost efficiency, and strategic growth initiatives in Q4 2024 earnings call.
The company aims to address challenges like disruptions, inflation, and underperforming stores while leveraging strengths in cash flow and cost-cutting.
Opportunities in store optimization, digital enhancement, and asset monetization are key areas for future growth.
Overall, Walgreens is navigating challenges, leveraging strengths, and pursuing opportunities to enhance financial performance and resilience.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

DEERFIELD, Ill.--(BUSINESS WIRE)--To honor the service and sacrifices of Americans who served in the armed forces, Walgreens is offering a weekend Memorial Day discount to all veterans, active duty military personnel and their immediate family members, including the families of those who lost their lives in service to their country. Beginning May 27 through May 30, customers with a myWalgreens membership and valid military ID or proof of service will receive 20 percent off regularly priced prod

Walgreens Honors Veterans, Active Duty Military and Their Families with Weekend Discount in Honor of Memorial Day Friday, May 27 through Monday, May 30

Cummins

Chevron

Lowe's

Microsoft

Target

During market corrections, dividend stocks provide passive income to help offset losses. Here are seven undervalued dividend stocks to buy now.

7 Undervalued Dividend Stocks to Buy Now

AGNC Investment

Antero Midstream Partners

These passive income powerhouses, with yields ranging from 4.4% to 11.9%, can generate some serious wealth for patient investors.

3 High-Yield Dividend Stocks That Can Turn $300,000 Into $1 Million by 2030

AmerisourceBergen

DEERFIELD, Ill.--(BUSINESS WIRE)--WBA announced that it has sold 6.0 million shares of AmerisourceBergen Corporation common stock pursuant to Rule 144 at a price of $150 per share.

Walgreens Boots Alliance Sells Six Million Shares of AmerisourceBergen Corporation

CVS Health

Walmart

CVS Health Corp, Walgreens Boots Alliance Inc and Walmart Inc on Tuesday begin a first-of-its-kind trial to determine what the pharmacy chains owe for their role in the opioid epidemic in two Ohio counties, which are seeking $878 million.

Walgreens, CVS, Walmart begin $878 million opioid trial in Ohio

Walgreens Boots Alliance will pay $683 million to settle with the state of Florida to resolve claims it contributed to the opioid epidemic.

Walgreens Will Pay $683 Million To Settle Florida Opioid Cases

Pharmacy giant agrees to pay state government over 18-year period but does not admit to wrongdoing as part of the deal

Walgreens to pay $683m to settle claims it exacerbated opioid crisis in Florida

Walgreens Boots Alliance said on Thursday it has reached a $683 million settlement with Florida to resolve claims that the pharmacy chain exacerbated an opioid epidemic in the state.

Walgreens reaches $683 million opioid settlement with Florida

Walgreens Boots Alliance Inc. WBA, +3.54% announced Thursday that it has entered into a $683 million settlement with the state of Florida related to the dispensing of prescription opioids. The state will receive $620 million over 18 years, and Walgreens is paying $63 million in attorneys fees.

Walgreens announces $683 million opioid settlement with state of Florida

DEERFIELD, Ill.--(BUSINESS WIRE)--Walgreens Reaches Opioid Settlement with State of Florida

Walgreens Reaches Opioid Settlement with State of Florida

Walgreens has named a trio of executives to key leadership positions in the company, the drugstore chain announced Wednesday (May 4). New leaders Linh Peters (senior vice president and chief marketing officer) Luke Rauch (senior vice president and chief merchandising officer) and Bala Visalatha (senior vice president and chief product officer) are all set to […]

Walgreens Names 3 to Leadership Roles

DEERFIELD, Ill.--(BUSINESS WIRE)--Walgreens today announced three key executive leadership positions: Linh Peters, senior vice president and chief marketing officer; Luke Rauch, senior vice president and chief merchandising officer; Bala Visalatha, senior vice president and chief product officer. These leaders will begin their new roles in May. “I am thrilled to have Linh, Luke and Bala join the Walgreens retail products and customer leadership team, and I'm confident that their collective deca

Walgreens Appoints Three Additions to its Retail Products and Customer Leadership Team

There's something about drugstores that have a unique appeal to most American consumers. Easy accessibility, immediate need products and a convenient location to pick up their latest pharmaceuticals.

Walgreens Boots Alliance: Cheap Stock, but for Good Reasons

Walgreens has been simplifying and transforming its business at the same time. The company has a massive job to do, and is still full in its transition.

Walgreens: Continued Transformation

Amgen

Gilead Sciences

Intel

Kraft Heinz

The Nasdaq has been absolutely obliterated this year, down a stunning 21.2%, which puts the tech-heavy index firmly in bear market territory.

Why the 5 Highest-Yielding Nasdaq Stocks May Be the Best and Safest Value Buys Now

Walgreens is committed to selling its U.K. Boots pharmacy in 2022. Cash proceeds from the sale could pay down debt and/or be used to accelerate the U.S. store makeover effort into a higher-margin health and wellness business.

Walgreens: Selling Boots Could Revive Wall Street Interest

The S&P 500 Index (SPX) is headed towards an unseasonably bearish April.

History Says This is the Worst Dow Stock to Own in May

Abbott Labs

Intuitive Surgical

Pfizer

UnitedHealth Group

People will always need medical treatment regardless of what is going on with the economy, which makes stocks in the healthcare sector consistently reliable investments.

The 5 Best Healthcare Stocks To Own Right Now

AbbVie

Best Buy

Conagra Brands

Darden Restaurants

Fidelity National Financial

Southern Copper

Whether in a bull market, bear market, or something in-between, make these seven high-quality dividend stocks long-term portfolio holdings. The post 7 A-Rated Dividend Stocks to Buy Forever appeared first on InvestorPlace.

7 A-Rated Dividend Stocks to Buy Forever

DEERFIELD, Ill. & CHICAGO--(BUSINESS WIRE)--Village Medical at Walgreens primary care and pharmacy services help patients better manage their health, through easy access and high-quality care

Walgreens and VillageMD Expand to Massachusetts with Goal of Opening More Than 10 New Full-Service, Primary Care Practices by Early 2023

Apollo Global Management

(Reuters) -Indian conglomerate Reliance Industries Ltd and U.S. buyout firm Apollo Global Management are planning a joint bid for UK high street pharmacy chain Boots, a spokesperson for Apollo confirmed on Wednesday.

India's Reliance, Apollo Global plan joint bid for Walgreens' Boots business

Pharmacy chain Walgreens Boots Alliance and other defendants on Tuesday said they were not to blame for the opioid crisis in San Francisco, and that they acted responsibly when providing legal medications to patients in pain.

Walgreens, drugmakers blame others for San Francisco's opioid crisis

Personal Care Brand to Prioritize Sustainability and Accessibility at the Integrated Healthcare and Pharmacy Retailer NEW YORK , April 26, 2022 /PRNewswire/ -- Hey Humans, a trailblazer in eco-conscious personal care has announced greater access to high performance, clean and sustainably-packaged personal care at over 6,0000 Walgreens retail locations nationwide and on walgreens.com. The brand's thoughtfully curated product assortment, made with sustainability in mind, is 99% plastic-free cross category.

Hey Humans Announces Exciting Expansion into Walgreens

Teva Pharmaceutical

San Francisco will square off on Monday against Walgreens Boots Alliance and three other companies accused of fueling an opioid crisis in the city, the first trial to target manufacturers, distributors and pharmacies over the addictive pain medicines.

Walgreens, Teva face San Francisco trial over opioid epidemic

NextEra Energy

Not all high-quality dividend stocks are created equally.

News for Walgreens Stock (WBA)